Use of Misoprostol in Hysteroscopic Myomectomy

Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.

NCT Number	NCT06049745
Lead Sponsor	Assuta Ashdod Hospital Collaborators: Assuta Medical Center
Conditions	Hysteroscopic Myomectomy
Enrollment	200 participants
Start Date	2023-11
Primary Completion	2026-08 (estimated)
Study Completion	2026-10 (estimated)
Updated on ClinicalTrials.gov	2023-09-22